Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Precision Health Diagnostic and Surveillance Network uses S Gene Target Failure (SGTF) combined with sequencing technologies to identify emerging SARS-CoV-2 variants

Rafael Guerrero-Preston, Vanessa Rivera-Amill, Karem Caraballo, Andrea Arias García, Raphael Sánchez Torres, Fernando Tadeu Zamuner, Claudio Zanettini, Matthew J. MacKay, Rachet Baits, Nike Beaubier, Gaurav Khullar, Jessica Metti, Una Pipic, Ana Purcell-Wiltz, Keilyn Vale, Gabriela Pérez, Lorena De Jesus, Yaima Miranda, Denise Ortiz, Amanda García Negrón, Liliana Viera, Alberto Ortiz, Jorge Acevedo, Josefina Romaguera, Ivonne Jiménez-Velazquez, Luigi Marchionni, José Rodríguez-Orengo, Adriana Baez, Christopher E. Mason, David Sidransky
doi: https://doi.org/10.1101/2021.05.04.21256012
Rafael Guerrero-Preston
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rguerrero@lifegenedna.com
Vanessa Rivera-Amill
2Center for Research Resources, Ponce Health Sciences University-Ponce Research Institute, Ponce, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karem Caraballo
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Arias García
2Center for Research Resources, Ponce Health Sciences University-Ponce Research Institute, Ponce, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raphael Sánchez Torres
2Center for Research Resources, Ponce Health Sciences University-Ponce Research Institute, Ponce, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Tadeu Zamuner
3Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Zanettini
4Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J. MacKay
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachet Baits
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nike Beaubier
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaurav Khullar
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Metti
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Una Pipic
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Purcell-Wiltz
1LifeGene-Biomarks, Inc, Puerto Rico
6Biology Department, University of Puerto Rico, Río Piedras, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keilyn Vale
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriela Pérez
7Neurology Medicine Department, Palmetto General Hospital, Miami, Florida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorena De Jesus
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaima Miranda
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise Ortiz
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda García Negrón
1LifeGene-Biomarks, Inc, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liliana Viera
8Department of Surgery, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Ortiz
9Internal Medicine Department, University of Puerto Rico School of Medicine, San, Juan Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Acevedo
9Internal Medicine Department, University of Puerto Rico School of Medicine, San, Juan Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josefina Romaguera
10Obstetrics and Gynecology Department, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivonne Jiménez-Velazquez
9Internal Medicine Department, University of Puerto Rico School of Medicine, San, Juan Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Marchionni
4Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, Cornell University, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Rodríguez-Orengo
10Obstetrics and Gynecology Department, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana Baez
11Otolaryngology Department, University of Puerto Rico School of Medicine, San Juan, Puerto Rico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher E. Mason
5Tempus Labs, Inc, Chicago, Illinois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Sidransky
3Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Several genomic epidemiology tools have been developed to track the public and population health impact of SARS-CoV-2 community spread worldwide. A SARS-CoV-2 Variant of Concern (VOC) B.1.1.7, known as 501Y.V1, which shows increased transmissibility, has rapidly become the dominant VOC in the United States (US). Our objective was to develop an evidenced-based genomic surveillance algorithm that combines RT-PCR and sequencing technologies to identify VOCs. Deidentified data were obtained from 508,969 patients tested for COVID-19 with the TaqPath COVID-19 RT-PCR Combo Kit (ThermoFisher) in four CLIA certified clinical laboratories in Puerto Rico (n=86,639) and in three CLIA certified clinical laboratories in the US (n=422,330). TaqPath data revealed a frequency of S Gene Target Failure (SGTF) >47% for the last week of March 2021, in both Puerto Rico and US laboratories. The monthly frequency of SGTF in Puerto Rico steadily increased exponentially from 4% in November 2020 to 47% in March 2021.The weekly SGTF rate in US samples was high (>8%) from late December to early January, and then also increased exponentially through April (48%). The exponential increase in SGFT prevalence in Puerto Rico is concurrent with a sharp increase in VOCs among all SARS-CoV-2 sequences from Puerto Rico uploaded to GISAID (n=461). B.1.1.7 frequency increased from <1% in the last week of January 2021 to 51.5% of viral sequences from Puerto Rico collected in the last week of March 2021. The exponential increase in SGTF and B.1.1.7 prevalence in Puerto Rico and US requires an urgent response. According to the proposed evidence-based algorithm, approximately 50% of all positive samples should be managed as potential B.1.1.7 carriers with VOC quarantine and contact tracing protocols while their lineage is confirmed by WGS in surveillance laboratories. Patients infected with VOCs should be effectively triaged for isolation, contact tracing and follow-up treatment purposes.

Competing Interest Statement

M.J.M., R.B., N.B., G.K., J.M., C.E.M., and U.P., work for Tempus Labs. R.G.P. works for LifeGene-Biomarks. All other authors declare no competing interests.

Funding Statement

This research was supported by: National Institute on Minority Health and Health Disparities Small Business Innovation Research Fast Track Phase 1 / Phase 2 award (R44MD014911) and Fideicomiso de Ciencia y Tecnologia de Puerto Rico Small Business Innovation Research Phase 1 Cash Match Award (R. Guerrero-Preston); MD007579: Research Centers in Minority Institutions Center for Research Resources, and Puerto Rico Science and Technology Research Trust (V. Rivera-Amill) under agreement 2020-00259; and National Cancer Institute U01CA84986 (D. Sidransky).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Puerto Rico Medical Sciences Campus (MSC) IRB approval # IRB2770120.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Materials availability Data availability Genomic data are available on GISAID (see Supplemental S3 for accession numbers). Supplemental Information Description Supplemental S1. Supplemental Methods, Supplemental Resutls, Supplemental Tables, Supplemental Notes. Supplemental S2. Data for Figures 2-4. Supplemental S3. List of SARS-CoV-2 sequences used in this study and author acknowledgements.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted May 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Precision Health Diagnostic and Surveillance Network uses S Gene Target Failure (SGTF) combined with sequencing technologies to identify emerging SARS-CoV-2 variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Precision Health Diagnostic and Surveillance Network uses S Gene Target Failure (SGTF) combined with sequencing technologies to identify emerging SARS-CoV-2 variants
Rafael Guerrero-Preston, Vanessa Rivera-Amill, Karem Caraballo, Andrea Arias García, Raphael Sánchez Torres, Fernando Tadeu Zamuner, Claudio Zanettini, Matthew J. MacKay, Rachet Baits, Nike Beaubier, Gaurav Khullar, Jessica Metti, Una Pipic, Ana Purcell-Wiltz, Keilyn Vale, Gabriela Pérez, Lorena De Jesus, Yaima Miranda, Denise Ortiz, Amanda García Negrón, Liliana Viera, Alberto Ortiz, Jorge Acevedo, Josefina Romaguera, Ivonne Jiménez-Velazquez, Luigi Marchionni, José Rodríguez-Orengo, Adriana Baez, Christopher E. Mason, David Sidransky
medRxiv 2021.05.04.21256012; doi: https://doi.org/10.1101/2021.05.04.21256012
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Precision Health Diagnostic and Surveillance Network uses S Gene Target Failure (SGTF) combined with sequencing technologies to identify emerging SARS-CoV-2 variants
Rafael Guerrero-Preston, Vanessa Rivera-Amill, Karem Caraballo, Andrea Arias García, Raphael Sánchez Torres, Fernando Tadeu Zamuner, Claudio Zanettini, Matthew J. MacKay, Rachet Baits, Nike Beaubier, Gaurav Khullar, Jessica Metti, Una Pipic, Ana Purcell-Wiltz, Keilyn Vale, Gabriela Pérez, Lorena De Jesus, Yaima Miranda, Denise Ortiz, Amanda García Negrón, Liliana Viera, Alberto Ortiz, Jorge Acevedo, Josefina Romaguera, Ivonne Jiménez-Velazquez, Luigi Marchionni, José Rodríguez-Orengo, Adriana Baez, Christopher E. Mason, David Sidransky
medRxiv 2021.05.04.21256012; doi: https://doi.org/10.1101/2021.05.04.21256012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (502)
  • Anesthesia (110)
  • Cardiovascular Medicine (1234)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (530)
  • Epidemiology (10015)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2449)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1638)
  • Health Policy (751)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11862)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2278)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (453)
  • Occupational and Environmental Health (535)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4829)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (651)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)